Stay updated with breaking news from Therapeutic Development Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note published on Wednesday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of NAVB opened at $0.06 on Wednesday. Navidea Biopharmaceuticals has a one year low of $0.02 and a one year high of […]
Analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research note issued on Wednesday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Up 8.9 % Shares of NYSE NAVB opened at $0.06 on Wednesday. The stock has a fifty day moving average price […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Monday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance NYSE:NAVB opened at $0.05 on Monday. The firm’s fifty day moving average is $0.06 and its 200-day moving average is $0.07. Navidea Biopharmaceuticals […]
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of Navidea Biopharmaceuticals stock opened at $0.05 on Friday. The business has a fifty day simple moving average of $0.06 […]
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Saturday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Up 2.0 % Shares of NAVB opened at $0.06 on Friday. Navidea Biopharmaceuticals has a 12-month low of $0.02 and a 12-month high […]